It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

vaccinations

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'

World / Science & Health Nov 19, 2020

Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'

Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.

China takes risk in rushing to use unproven coronavirus vaccines

Asia Pacific / Science & Health Nov 18, 2020

China takes risk in rushing to use unproven coronavirus vaccines

by Sui-lee Wee and Elsie Chen

China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.

Sinovac's COVID-19 vaccine induces quick immune response, study finds

Asia Pacific / Science & Health Nov 18, 2020

Sinovac's COVID-19 vaccine induces quick immune response, study finds

Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday. While the early to mid-stage trials were not designed to assess ...

Pfizer reaches safety milestone for COVID-19 vaccine, CEO says

World / Science & Health Nov 18, 2020

Pfizer reaches safety milestone for COVID-19 vaccine, CEO says

Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators. Speaking at a virtual conference hosted by The ...

How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine

World / Science & Health | FOCUS Nov 18, 2020

How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine

by Michael Erman and Julie Steenhuysen

Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.

Moderna’s COVID-19 vaccine: What you need to know

World / Science & Health Nov 17, 2020

Moderna’s COVID-19 vaccine: What you need to know

by Carl Zimmer

Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there’s going to be a way out of the pandemic.

WHO warns against COVID-19 complacency after Moderna vaccine news

World / Science & Health Nov 17, 2020

WHO warns against COVID-19 complacency after Moderna vaccine news

"Right now we are extremely concerned by the surge in cases we are seeing in some countries," WHO director-general Tedros Adhanom Ghebreyesus told a news briefing.

How the Moderna and Pfizer coronavirus vaccines stack up

World / Science & Health Nov 17, 2020

How the Moderna and Pfizer coronavirus vaccines stack up

by James Paton

The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.

Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection

World Nov 16, 2020

Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection

A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.

China under pressure to reveal vaccine data after Pfizer success

Asia Pacific Nov 13, 2020

China under pressure to reveal vaccine data after Pfizer success

While Beijing has hailed the progress on its own own COVID-19 vaccines, it has so far yet to back this up with evidence.

Moderna COVID-19 vaccine trial reaches key goal to gauge merit

World / Science & Health Nov 12, 2020

Moderna COVID-19 vaccine trial reaches key goal to gauge merit

The bet among top experts in the field is that Moderna’s therapy will likely prove to be highly effective.

Russia says its Sputnik V COVID-19 vaccine is 92% effective

World / Science & Health Nov 12, 2020

Russia says its Sputnik V COVID-19 vaccine is 92% effective

Experts welcomed the news but warned that the results were only based on a small number of trial volunteers who had contracted COVID-19.

« 1 … 65 66 67 … 74 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times